ALPINE IMMUNE SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.95 USD | +0.02% |
|
+0.54% | +240.77% |
| May. 10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
| May. 09 | Alpine Immune Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Bio Therapeutic Drugs | +0.02% | +0.54% | +240.77% | +694.98% | +1,000.85% | 4.46B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALPN Stock
- Charts Alpine Immune Sciences, Inc.
- Comparison Chart
